February is American Heart Month, a time when everybody is encouraged to focus on their cardiovascular health. According to the Centers for Disease Control and Prevention, heart disease is the leading ...

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

"AISAP is proud to collaborate with forward-thinking practices and community partners like Amavita," said Roni Attali, AISAP ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of ...

The term “heart failure” sounds as if the heart has stopped working. Although it’s a serious condition and requires timely medical attention, the words actually mean that the heart isn’t able to keep ...

EBR Systems is super confident the US medical gatekeeper will approve Wise, the world's first wireless pacemaker device.

Learn about this local family's heart journey + how you can help save lives during the Heart Walk in Birmingham on March 8. NowPartner #AmericanHeartAssociation #BhamHeartWalk #WestALHeartWalk ##HSVHe ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

The primary reasons for exclusion were age over 85 years at the time of data analysis (29%), followed by a diagnosis of another cardiomyopathy (16%), and symptomatic valvular heart disease causing ...